Baxter begins marketing generic azithromycin antibiotic for injection

By Angela McDaniels

Seattle, March 23 - Baxter Healthcare Corp. said it launched its generic azithromycin for injection on Thursday. Azithromycin is the generic version of Pfizer's Zithromax antibiotic.

Pfizer will manufacture the product, and Baxter will sell and market it in the United States.

The launch marks the first time Baxter has been granted exclusive authorization by a pharmaceutical company to market a generic version of its brand product, according to a company news release.

Deerfield, Ill.-based Baxter Healthcare is the principal U.S. operating subsidiary of Baxter International Inc., which develops medical devices, pharmaceuticals and biotechnology.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.